Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.

[1]  J. Sinisalo,et al.  Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Rationale and Design of the Multicenter Randomized Occlusion-AF Trial. , 2021, American heart journal.

[2]  H. Diener,et al.  Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation. , 2021, JACC. Cardiovascular interventions.

[3]  G. Lip,et al.  Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation , 2020, European heart journal supplements : journal of the European Society of Cardiology.

[4]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[5]  P. Neužil,et al.  Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. , 2020, Journal of the American College of Cardiology.

[6]  H. Diener,et al.  Left atrial appendage occlusion with the Amplatzer™ Amulet™ device: full results of the prospective global observational study. , 2020, European heart journal.

[7]  D. Werring,et al.  Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation , 2020, Annals of neurology.

[8]  B. Meier,et al.  Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry. , 2020, Revista Española de Cardiología.

[9]  S. Connolly,et al.  Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source , 2018, The New England journal of medicine.

[10]  Saibal Kar,et al.  5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. , 2017, Journal of the American College of Cardiology.

[11]  J. Daubert,et al.  Incidence and Predictors of Left Atrial Appendage Thrombus in Patients Treated With Nonvitamin K Oral Anticoagulants Versus Warfarin Before Catheter Ablation for Atrial Fibrillation. , 2017, The American journal of cardiology.

[12]  C. Held,et al.  Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation , 2016, Heart.

[13]  Dhanunjaya R. Lakkireddy,et al.  Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[14]  Henrik Toft Sørensen,et al.  The Danish Civil Registration System as a tool in epidemiology , 2014, European Journal of Epidemiology.

[15]  S. Johnsen,et al.  Registration of acute stroke: validity in the Danish Stroke Registry and the Danish National Registry of Patients , 2013, Clinical epidemiology.

[16]  A. Riis,et al.  Registration of acute medical hospital admissions in the Danish National Patient Registry: a validation study , 2013, Clinical epidemiology.

[17]  Mårten Rosenqvist,et al.  Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. , 2012, European heart journal.

[18]  B. Lewis,et al.  Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial , 2012, The Lancet Neurology.

[19]  G. Breithardt,et al.  Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF , 2012, The Lancet Neurology.

[20]  K. Helweg-larsen.  The Danish Register of Causes of Death , 2011, Scandinavian journal of public health.

[21]  Jun Zhu,et al.  Apixaban in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[22]  L. Laine,et al.  Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. , 2006, The American journal of medicine.

[23]  Deepak L. Bhatt,et al.  Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. , 2005, The American journal of cardiology.